Literature DB >> 11454427

Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders.

T S Wan1, S K Ma, W Y Au, L C Chan.   

Abstract

We report two cases of hematological malignancies, comprising a case of myelodysplastic syndrome (MDS) that rapidly evolved into acute myeloid leukemia, and a case of myeloproliferative disorder (MPD), in which der(1;18)(q10;q10) was found as the sole acquired karyotypic abnormality. This observation indicates that the unbalanced translocation is a recurrent aberration in myeloid disorders. To the best of our knowledge, centromeric fusion between long arms of chromosomes 1 and 18, leading to a normal chromosome 18 substituted with a der(1;18) chromosome, is novel and has not been described in cancer. Mechanistically, either trisomy 1q or monosomy 18p that results from the translocation may potentially contribute to leukemogenesis. Finally, chromosomes with large constitutive heterochromatin bands such as chromosome 1 may be at risk of centromeric instability and be predisposed to centromeric fusion with other chromosomes.

Entities:  

Mesh:

Year:  2001        PMID: 11454427     DOI: 10.1016/s0165-4608(01)00391-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  A case of myelodysplastic syndrome with a der(1;18)(q10;q10) translocation.

Authors:  Jung-Sook Ha; Dong-Suk Jeon
Journal:  Blood Res       Date:  2014-06-25

2.  A rare der(Y)t(Y;1)(q12;q12) in a patient with post-polycythemic myelofibrosis: a case report.

Authors:  Masahiro Manabe; Osami Takeda; Junya Okita; Teruhito Takakuwa; Naonori Harada; Hirofumi Nakano; Shuichiro Okamoto; Yasutaka Aoyama; Takeo Kumura; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Am J Blood Res       Date:  2013-05-05

3.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.